LGT Group Foundation Buys 7,357 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

LGT Group Foundation raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 9.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 85,932 shares of the medical instruments supplier’s stock after purchasing an additional 7,357 shares during the period. LGT Group Foundation’s holdings in DENTSPLY SIRONA were worth $1,631,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XRAY. Wealth Enhancement Advisory Services LLC increased its position in shares of DENTSPLY SIRONA by 43.9% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,038 shares of the medical instruments supplier’s stock worth $326,000 after acquiring an additional 3,671 shares in the last quarter. State of Alaska Department of Revenue increased its position in shares of DENTSPLY SIRONA by 2.4% during the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after acquiring an additional 560 shares in the last quarter. US Bancorp DE increased its position in shares of DENTSPLY SIRONA by 6.0% during the third quarter. US Bancorp DE now owns 59,553 shares of the medical instruments supplier’s stock worth $1,612,000 after acquiring an additional 3,397 shares in the last quarter. Janney Montgomery Scott LLC increased its position in shares of DENTSPLY SIRONA by 45.4% during the third quarter. Janney Montgomery Scott LLC now owns 43,203 shares of the medical instruments supplier’s stock worth $1,169,000 after acquiring an additional 13,491 shares in the last quarter. Finally, Van ECK Associates Corp bought a new stake in shares of DENTSPLY SIRONA during the third quarter worth about $42,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $15.99 on Tuesday. The company’s fifty day moving average price is $18.83 and its 200-day moving average price is $21.46. The firm has a market capitalization of $3.18 billion, a price-to-earnings ratio of -7.72, a PEG ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA Inc. has a one year low of $15.94 and a one year high of $34.28. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.00%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s payout ratio is -14.07%.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.52% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on XRAY shares. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday. Wells Fargo & Company reduced their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday. Finally, UBS Group dropped their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $23.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.